[Stages of drug treatment in threatened premature labor].
Thoulon
J M
JM
Département de Gynécologie-Obstétrique et Reproduction, Hôtel-Dieu, Lyon.
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use*; D000420:Albuterol / Q000627:therapeutic use; D005260:Female; D005280:Fenoterol / Q000627:therapeutic use; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use; D007660:Ketoprofen / Q000627:therapeutic use; D009543:Nifedipine / Q000627:therapeutic use; D007752:Obstetric Labor, Premature / Q000517:prevention & control*; D011247:Pregnancy; D011374:Progesterone / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D012312:Ritodrine / Q000627:therapeutic use; D013726:Terbutaline / Q000627:therapeutic use; D014700:Verapamil / Q000627:therapeutic use
D000318:Adrenergic beta-Agonists; D005280:Fenoterol; D011374:Progesterone; D007660:Ketoprofen; D014700:Verapamil; D012312:Ritodrine; D009543:Nifedipine; D013726:Terbutaline; D000420:Albuterol; D007213:Indomethacin
Les étapes du traitement médical de la menace d'accouchement prématuré.